SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Release:

U.S. News & World Report Honors 7 SynCardia Certified Centers Among "Best Children's Hospitals" for Cardiology and Heart Surgery

Two Additional Top Children's Hospitals Ready to Perform 1st SynCardia Total Artificial Heart Implant

 

On May 21, 20-year-old Tiernee Gonzalez became the first SynCardia Total Artificial Heart patient to be discharged from Cincinnati Children’s to wait for a matching donor heart at home using the Freedom® portable driver.

TUCSON, Ariz. – June 13, 2013 – SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that U.S. News & World Report has named seven SynCardia Certified Centers among the nation's "Best Children's Hospitals" for cardiology and heart surgery in its annual rankings for 2013-2014.

"The SynCardia temporary Total Artificial Heart has opened the flood gates in respect to the treatment possibilities for a quickly growing population of children in heart failure, including adolescents suffering from chronic rejection of their transplanted heart, end-stage heart failure accompanied by multiple congenital defects and a late-stage failing Fontan circulation," said Dr. David L.S. Morales, chief of pediatric cardiothoracic surgery at Cincinnati Children's Hospital Medical Center, which ranked in the top five.

SynCardia Certified Centers included in the list were:

  • #2 Children's Hospital of Philadelphia (CHOP)
  • #3 Texas Children's Hospital
  • #5 Cincinnati Children's Hospital Medical Center
  • #11 Children's Hospital of Wisconsin
  • #26 Mattel Children's Hospital UCLA
  • #32 Shands Hospital for Children at the University of Florida
  • #34 Phoenix Children's Hospital

In addition to the seven hospitals listed above, #9 Lucile Packard Children's Hospital at Stanford and #43 Arkansas Children's Hospital have completed the first two phases of SynCardia's four-phase certification program and are ready to perform their first proctored implant once an appropriate patient has been identified.

Clinical research, surgical survival and ability to prevent bloodstream infections were among the factors making up 75% of the score used for the rankings. The other 25% reflects how many of 450 pediatric cardiologists and heart surgeons surveyed in 2011, 2012 and 2013 recommended the hospital.

CAUTION - The Freedom® portable driver is an investigational device, limited by United States law to investigational use.

###

About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

Follow SynCardia: Facebook | Twitter | LinkedIn | Google+

SynCardia Contact:
Janelle Drumwright, jdrumwright@syncardia.com, (520) 547-7463

 

 

Search offcanvas